Pamabrom
CAS: 606-04-2
Ref. 3D-FP26743
5g | Ausgelaufen | ||
10g | Ausgelaufen | ||
25g | Ausgelaufen | ||
50g | Ausgelaufen | ||
100g | Ausgelaufen |
Produktinformation
- 8-Bromo-3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione 2-amino-2-methyl-1-propanol2-Amino-2-methyl-1-propanol 8-bromotheophyllinateP redema
- 1-Propanol, 2-amino-2-methyl-, compd. with 8-bromo-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
- 1-Propanol, 2-amino-2-methyl-, compd. with 8-bromotheophylline (1:1)
- 1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-1,3-dimethyl-, compd. with 2-amino-2-methyl-1-propanol (1:1)
- 1H-Purine-2,6-dione, 8-bromo-3,9-dihydro-1,3-dimethyl-, compd. with 2-amino-2-methyl-1-propanol (1:1)
- 2-Amino-2-Methylpropanol 8-Bromotheophyllinate
- 2-Amino-2-methyl-1-propanol 8-bromotheophyllinate
- 8-bromo-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione - 2-amino-2-methylpropan-1-ol (1:1)
- Predema
- Premsyn PMS
- Mehr Synonyme anzeigen
- Sunril
- Theophylline, 8-bromo-, compd. with 2-amino-2-methyl-1-propanol (1:1)
Pamabrom is a nonsteroidal anti-inflammatory drug that belongs to the group of drugs called heterocyclic compounds. It has been shown to have a significant analgesic effect on experimental animals in vivo, and also has an activity on the central nervous system. Pamabrom has also been shown to be a potential candidate for the treatment of congestive heart failure. The mechanism of action is not well understood, but it may involve interference with prostaglandin synthesis or inhibition of cyclooxygenase enzymes. The effects of pamabrom are reversible, and there are no known long-term side effects.